Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Mid-Afternoon Market Update: Sage Therapeutics Drops After Brexanolone Drug Fails Phase III Testing; Aldeyra Therapeutics Shares Gain

By: Benzinga via Benzinga

September 12, 2017 at 14:41 PM EDT

Toward the end of trading Tuesday, the Dow traded up 0.27 percent to 22,116.82 while the NASDAQ climbed 0.18 percent to 6,443.63. The ...

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Mid-Afternoon Market Update: Sage Therapeutics Drops After Brexanolone Drug Fails Phase III Testing; Aldeyra Therapeutics Shares Gain

Popular Pages